CXCR4+ mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis
Tumor-initiating cells (TICs) share features and regulatory pathways with normal stem cells, yet how the stem cell niche contributes to tumorigenesis remains unclear. Here, we identify CXCR4<sup>+</sup> macrophages as a niche population enriched in normal mammary ducts, where they promote the regenerative activity of basal cells in response to luminal cell-derived CXCL12. CXCL12 triggers AKT-mediated stabilization of β-catenin, which induces Wnt ligands and pro-migratory genes, enabling intraductal macrophage infiltration and supporting regenerative activity of basal cells. Notably, these same CXCR4<sup>+</sup> niche macrophages regulate the tumor-initiating activity of various breast cancer subtypes by enhancing TIC survival and tumor-forming capacity, while promoting early immune evasion through regulatory T cell induction. Furthermore, a CXCR4<sup>+</sup> niche macrophage gene signature correlates with poor prognosis in human breast cancer. These findings highlight the pivotal role of the CXCL12-CXCR4 axis in orchestrating interactions between niche macrophages, mammary epithelial cells, and immune cells, thereby establishing a supportive niche for both normal tissue regeneration and mammary tumor initiation.
Authors
- Natalie Sauerwald (ORCID: https://orcid.org/0000-0002-9434-0940)
- Chandra L. Theesfeld
- Geoffrey Vargas
- Jean Arly Volmar
- Christina J. DeCoste (ORCID: https://orcid.org/0000-0003-4002-0244)
- Gary Laevsky (ORCID: https://orcid.org/0000-0001-6200-1090)
- Yibin Kang (ORCID: https://orcid.org/0000-0002-1626-6730)
- Yong Wei (ORCID: https://orcid.org/0000-0002-1034-649X)
- Jennifer Miller (ORCID: https://orcid.org/0000-0002-0615-935X)
- Wei Wang (ORCID: https://orcid.org/0000-0002-6558-4858)
- Sha Wang (ORCID: https://orcid.org/0000-0002-3945-2763)
- Eun-Mi Lee (ORCID: https://orcid.org/0000-0002-1995-2867)
- Jason J Hong (ORCID: https://orcid.org/0000-0002-4631-131X)
- Xiang Hang
Institutions
- Rutgers, The State University of New Jersey (US)
- Princeton University (US)
- Ludwig Cancer Research (US)
- Flatiron Health (United States) (US)
- Flatiron Institute (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-05-25
- DOI
- https://doi.org/10.1038/s41467-025-59972-z
- Citations
- 11
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 8.77
Funders
- U.S. Department of Defense
- American Cancer Society
- Susan G. Komen for the Cure
- Breast Cancer Research Foundation
- Princeton University
- Rutgers Cancer Institute of New Jersey
- Brewster Foundation
- Susan G. Komen
- Ludwig Institute for Cancer Research
- National Institutes of Health
- National Cancer Institute